Anuncio
Anuncio
RNAZ
TransCode Therapeutics, Inc. Common Stock
7.92
USDPatrocinado
-0.01
-0.13%
09 ene, 15:59 UTC -5
Cerrado
Post-mercado
7.99
+0.07
+0.82%
Informes de beneficios de RNAZ
Ratio de Sorpresa Positivo
RNAZ superó 5 de las últimas 11 estimaciones.
45%
Próximo informe
Fecha del próximo informe
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Cambio implícito desde Q-- -- (Revenue/ EPS)
--
/--
Cambio implícito desde Q-- -1 (Revenue/ EPS)
--
/--
TransCode Therapeutics, Inc. Common Stock earnings per share and revenue
On --, RNAZ reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to -- --, -- analistas forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Preguntas frecuentes
What were TransCode Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q-- --?
For Q-- --, TransCode Therapeutics, Inc. Common Stock reported EPS of --, Inline estimates by --, and revenue of --, -- -- expectations.
How did the market react to TransCode Therapeutics, Inc. Common Stock's Q-- -- earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is TransCode Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for --.
What are the forecasts for TransCode Therapeutics, Inc. Common Stock's next earnings report?
Based on --
analistas, TransCode Therapeutics, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Cheque FXEmpire's Earnings Calendar for today's list of reporting companies.
Anuncio